Mystery provider behind plans for $1B hospital complex in Indiana

A healthcare real estate company is planning a $1 billion project for a large hospital and medical offices on a site in Carmel, Indiana, with signs pointing to St. Vincent Health as the group behind the property’s development.

According to the Indianapolis Business Journal, Ambrose Property Group has filed plans to redevelop a 30-acre site into a five-building medical complex. The plans don’t specify what provider is involved and Ambrose refused to discuss the project, but in a joint venture with another company, Bremner Real Estate, Ambrose has contacted owners of 13 homes adjacent to the site about buying their property.

"We are engaged by a major health system to plan, develop, and construct a large inpatient hospital, supporting medical office buildings, and parking structures,” the letter read. “The new medical campus will enable our client to provide service excellence and innovative care for the surrounding communities.”

The rumored healthcare provider behind the plan, St. Vincent Health, has its main 800-bed hospital just three miles away. Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.